Atossa Therapeutics Inc ATOS

$1.96 +0.02 (1.03%)

Valuation

Market cap
20,258,000
Revenue TTM
$0
Net income TTM
$-34,770,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
56,300
Avg volume
73,556
Day's range
$1.85 – $2.00
Shares out
9,979,000
Stochastic %K
22%
Beta
1.38
Analysts
Strong Buy
Price target
$17.00

Price

Company profile

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in areas of significant unmet medical need in oncology in the United States. Its lead drug candidate is oral (Z)-endoxifen, a selective estrogen receptor modulator and selective estrogen receptor degrader currently in Phase 2 clinical development for the treatment and reduction of risk of breast cancer, as well as in other thera...

Show more

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in areas of significant unmet medical need in oncology in the United States. Its lead drug candidate is oral (Z)-endoxifen, a selective estrogen receptor modulator and selective estrogen receptor degrader currently in Phase 2 clinical development for the treatment and reduction of risk of breast cancer, as well as in other therapeutic areas. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is based in Seattle, Washington.

Industry
Biotechnology
Sector
Healthcare
Phone
206 588 0256
Website
https://www.atossatherapeutics.com
Address
448 NW Market Street, Suite 500, Seattle, United States

Latest news

Stocktwits

Bunster Nov 13, 9:54 PM
$ATOS is this breaking new? DUE TO COMMUNICATION SYSTEM WITH THE ATC ,DID FAA GROUND STOPPED ALL US FLIGHTS ?????
1 replies
Bunster Nov 13, 9:49 PM
$ATOS WIR ADDENDUM ER out this week. not bad . burn rate lower for q to like 6 ml 20 mil cash sept 30. Looks like at this rate cash till like july or august 2027.That 4 mil raise in june i think imo was a disaster and the market agreed with prime.They destroyed the pps for 2 lousy months of cash. imo imo anyone who didnt think it was a bad raise should not be trading or investing.. Back then i posted 7 weeks of cash, but that was off of a higher burn..Was anything posted on the er or is prime the first. So many bulls have blocked prime cause reality is not their forte so if a bull posted it i might not have seen it.Even though cash is better, that raise i think in june says to me they are capable of doing another one at any time.
0 replies
Bunster Nov 13, 9:05 PM
$ATOS week in review friday the 13th november 13 2026..pps 13c pre rs. 2 days in row close under 2.00. even hannibal cant spin that
0 replies
Babyballoon Nov 13, 7:06 PM
$ATOS CEO Quay is still a top tier scammer 😂
1 replies
NOYES Nov 13, 3:25 PM
$ATOS ready for 52 week low??
0 replies
dcajic2 Nov 13, 3:22 PM
$ATOS The fact is it’s still an early phase company that needs so much money to survive. Any money raised will severely dilute the stock. The thing with almost pre revenue companies the only winners are executives
0 replies
dcajic2 Nov 13, 3:21 PM
$ATOS End of the road is rapidly approaching. Once the data is released and is shown that it is not better than many drugs that are presently in development it’s over. Been a poorly run company for a very long time.
0 replies
TsaiShen Nov 12, 10:08 PM
$ATOS lol, just thought i'd swing by and say hello to the OGs. Hello OGs!
1 replies